Atsena Therapeutics Alternatives & Competitors
12 companies similar to Atsena Therapeutics — Clinical-stage gene therapy company developing treatments to reverse/prevent bli...
Companies similar to Atsena Therapeutics
Opus Genetics
Gene therapy company for inherited retinal diseases
Raleigh, United States
Renovacor
Advancing transformative therapies for cardiovascular disease
United Kingdom
Hunterian Medicine
Advancing cures for genetic diseases with innovative CRISPR delivery technology
Cambridge, United States
Rival Readout
Competing with Atsena Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Genenta Science (Nasdaq: GNTA)
Genenta is a clinical stage immuno-oncology company
Milan, Italy
AGTC
Visionary science for life-changing cures.
Alachua, United States
Lexeo Therapeutics
Advancing science with curative potential for both cardiovascular and APOE4 associated Alz...
New York, United States
Solid Biosciences
#TogetherWeAreSolid
Boston, United States
American Gene Technologies® International Inc.
Our mission is to leverage the power of gene and cell therapy to reduce human suffering fr...
Rockville, United States
Hemostemix Inc.
Clinical-stage biotech company commercializing ACP-01 as a treatment for cardiovascular di...
Canada
Immuneel Therapeutics Pvt. Ltd.
Accelerating access to Cell & Gene Therapies
Bengaluru, India
Adverum Biotechnologies
We are on a global mission to establish gene therapy as a new standard of care for the lea...
Redwood City, United Stat...
About Atsena Therapeutics
Atsena Therapeutics is a biotechnology startup focusing on clinical-stage ocular gene therapy for treating inherited forms of blindness. The company's flagship programs include ATSN-201 for X-linked retinoschisis (XLRS) and ATSN-101 for GUCY2D-associated Leber congenital amaurosis (LCA1). Notably, the company's innovat...
Clinical-stage Company, Ocular Gene Therapy, Inherited Blindness, ATSN-201, ATSN-101, LCA1, XLRS, Gene Therapy, Phase I/II Clinical Trial, Adeno-Associated Virus, University Of Florida, Research Triangle, Genetic Medicine, Blindness Treatment, Ocular Gene Therapy Pioneers
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Atsena Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Atsena Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
